Company Filing History:
Years Active: 2016
Title: Michèle Dargis: Innovator in Influenza Vaccine Development
Introduction
Michèle Dargis is a prominent inventor based in Québec, Canada. She has made significant contributions to the field of vaccine development, particularly in the synthesis of influenza virus-like particles. Her innovative work has the potential to enhance the effectiveness of influenza vaccines.
Latest Patents
Dargis holds a patent for a method of synthesizing influenza virus-like particles (VLPs) within a plant or a portion of a plant. This method involves the expression of influenza hemagglutinin (HA) of type A/California/04/09 in plants, followed by purification through size exclusion chromatography. The invention also includes a VLP comprising influenza HA protein of type A/California/04/09 and plant lipids. Additionally, it encompasses a nucleic acid encoding influenza HA of type A/California/04/09, as well as vectors. These VLPs may be utilized to formulate influenza vaccines or to enhance existing vaccines.
Career Highlights
Dargis is associated with Medicago Inc., a company that focuses on developing innovative vaccine solutions. Her work at Medicago has positioned her as a key player in the biotechnology sector, particularly in the area of plant-based vaccine production.
Collaborations
Throughout her career, Dargis has collaborated with notable colleagues, including Marc-Andre D'Aoust and Manon Couture. These collaborations have contributed to the advancement of her research and the development of effective vaccine technologies.
Conclusion
Michèle Dargis is a trailblazer in the field of influenza vaccine development, with her innovative methods and collaborations paving the way for future advancements in vaccine technology. Her contributions are vital in the ongoing fight against influenza and highlight the importance of innovation in public health.